Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Multi-Center Study to Determine the Safety and Efficacy of Erythropoietin Plus Pentoxifylline Versus Erythropoietin Alone for the Treatment of Anemia in Subjects With End Stage Renal Disease on Maintenance Hemodialysis

NCT01102218 is registered in ClinicalTrials.gov with Fresenius Medical Care North America as lead sponsor.

NCT NCT01102218
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01102218 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Multi-Center Study to Determine the Safety and Efficacy of Erythropoietin Plus Pentoxifylline Versus Erythropoietin Alone for the Treatment of Anemia in Subjects With End Stage Renal Disease on Maintenance Hemodialysis
Lead sponsor
Fresenius Medical Care North America
Phase
Phase 2
Overall status
Terminated
Start date
August 31, 2010
Completion date
January 31, 2012
Enrollment
48 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

end stage renal disease